Based on some reports, Rac-1 and RhoA, as two key members of Rho GTPases, are listed as two mediators of podocyte dysfunction and therefore, their inhibition might be beneficial for handling chronic kidney diseases (CKDs) [29, 30]. Here, RAC1 is linked to chronic kidney disease.